Viropil Tablet contains its active substance called Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) – 1 infection. Dolutegravir present in Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is an integrase strand transfer inhibitor. Emtricitabine and Tenofovir Lamivudine and Tenofovir disoproxil fumarate present in Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is a nucleoside analogue. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) works by reducing the viral load of HIV in your body. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) improves your immune system and reduces the risk of conditions associated with HIV infection. 

Viropil Tablet contains its active substance called Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is used to treat adults and children above the weight class 35kg only who are infected by HIV-1.

Viropil Tablet contains its active substance called Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is used to help control HIV infection. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) helps to decrease the amount of HIV in your body thus your immunity works better by reducing your chance of getting HIV complications like co-infections and other cancers. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is not a cure for HIV infection, it improves immunity that results in longevity of life. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is recommended for use in children from 35kgs and in adults.

Viropil Tablet contains its active substance called Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is indicated in case of HIV-1 infection that causes AIDS in humans. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) boost immunity of the affected hosts. Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is indicated in adults and children above 35kgs.

Viropil Tablet contains its active substance called Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate. Dolutegravir present in Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is a inhibits strand transfer activity of integrase in DNA thus blocks replication of HV-1. Lamivudine present in Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is an analogue that is phosphorylated to its active forms lamivudine triphosphate that incorporated into the nucleotide and inhibits the action of HIV-1 reverse transcriptase. Tenofovir disoproxil fumarate present in Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) is an analogue of adenosine 5-monophosphate which is converted to tenofovir after hydrolysis after which tenofovir inhibits HIV-1 reverse transcriptase. Tenofovir competes with AMP as a substrate and competes to incorporate themselves into the DNA strand thus stops the replication of viral particles. Thus, the active HIV molecules becomes inactive and further reproduction and multiplication process is stopped.

Viropil Tablet (Dolutegravir 50mg + Lamivudine 300mg + Tenofovir disoproxil fumarate 300mg) contains an integrase inhibitor and nucleoside reverse transcriptase inhibitor. Dolutegravir inhibits transfer of integrase in DNA and Lamivudine and tenofovir incorporates themselves into the DNA thus stops the replication of viral particles. Thereby preventing the formation of mature virus particles into infectious virions that spreads the infection.